Another paradox in Crohn's disease: new onset of psoriasis in a patient receiving tumor necrosis factor-alpha antagonist

Inflamm Bowel Dis. 2007 Aug;13(8):1059-61. doi: 10.1002/ibd.20137.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / adverse effects*
  • Crohn Disease / drug therapy*
  • Gastrointestinal Agents / adverse effects*
  • Humans
  • Infliximab
  • Male
  • Psoriasis / chemically induced*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab